{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:35:30Z","timestamp":1783049730877,"version":"3.54.6"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KFO274"],"award-info":[{"award-number":["KFO274"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MU 2928\/2-1"],"award-info":[{"award-number":["MU 2928\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002345","name":"Eberhard Karls Universit\u00e4t T\u00fcbingen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.atherosclerosis.2014.09.010","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T19:57:07Z","timestamp":1412107027000},"page":"426-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Impact of counterbalance between macrophage migration inhibitory factor and its inhibitor Gremlin-1 in patients with coronary artery disease"],"prefix":"10.1016","volume":"237","author":[{"given":"Iris I.","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin A.L.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Karathanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Sch\u00f6nleber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhumita","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Seizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Schaeffeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meinrad","family":"Gawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2014.09.010_bib1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nm1567","article-title":"MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment","volume":"13","author":"Bernhagen","year":"2007","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.09.010_bib2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/01.CIR.0000109201.72441.09","article-title":"Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice","volume":"109","author":"Schober","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.09.010_bib3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cardiores.2004.09.020","article-title":"Evidence for vascular macrophage migration inhibitory factor in destabilization of human atherosclerotic plaques","volume":"65","author":"Kong","year":"2005","journal-title":"Cardiovasc Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.09.010_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2004.08.030","article-title":"Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques","volume":"178","author":"Kong","year":"2005","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.09.010_bib5","doi-asserted-by":"crossref","first-page":"e38376","DOI":"10.1371\/journal.pone.0038376","article-title":"Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response","volume":"7","author":"M\u00fcller","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.09.010_bib6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.atherosclerosis.2007.12.025","article-title":"Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA\/KORA Augsburg case-cohort study, 1984\u20132002","volume":"200","author":"Herder","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.09.010_bib7","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1182\/blood-2010-06-291930","article-title":"Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2","volume":"116","author":"Mitola","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2014.09.010_bib8","doi-asserted-by":"crossref","first-page":"31635","DOI":"10.1074\/jbc.M113.477745","article-title":"Gremlin-1 is an inhibitor of macrophage migration inhibitory factor and attenuates atherosclerotic plaque growth in ApoE\u2212\/\u2212 mice","volume":"288","author":"Muller","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2014.09.010_bib9","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/CIRCULATIONAHA.106.683227","volume":"116","author":"Chang","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.09.010_bib10","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2014.09.010_bib11","first-page":"2","article-title":"World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects","volume":"35","year":"1997","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.atherosclerosis.2014.09.010_bib12","first-page":"45","article-title":"ICH harmonised tripartite guideline. Guideline for good clinical practice","volume":"47","year":"2001","journal-title":"J.\u00a0Postgrad. Med."},{"key":"10.1016\/j.atherosclerosis.2014.09.010_bib13","first-page":"12","volume":"9","year":"2002","journal-title":"Med. Etika Bioet."},{"key":"10.1016\/j.atherosclerosis.2014.09.010_bib14","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1161\/01.CIR.103.21.2550","article-title":"Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction \u2013 a TIMI 14 substudy","volume":"103","author":"Gibson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.09.010_bib15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.atherosclerosis.2012.07.027","article-title":"Paucity of CD34-positive cells and increased expression of high-mobility group box 1 in coronary thrombus with type 2 diabetes mellitus","volume":"224","author":"Yamashita","year":"2012","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.09.010_bib16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.92.3.657","article-title":"Coronary plaque disruption","volume":"92","author":"Falk","year":"1995","journal-title":"Circulation"},{"issue":"4 Suppl.\u00a0S","key":"10.1016\/j.atherosclerosis.2014.09.010_bib17","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1016\/S0735-1097(02)02834-6","article-title":"Mechanisms of plaque vulnerability and rupture","volume":"41","author":"Shah","year":"2003","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"14","key":"10.1016\/j.atherosclerosis.2014.09.010_bib18","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000087480.94275.97","article-title":"From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2014.09.010_bib19","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1161\/01.CIR.0000087481.55887.C9","article-title":"From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2014.09.010_bib20","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/CIRCULATIONAHA.107.729125","article-title":"Macrophage migration inhibitory factor in cardiovascular disease","volume":"117","author":"Zernecke","year":"2008","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2014.09.010_bib21","doi-asserted-by":"crossref","first-page":"e76206","DOI":"10.1371\/journal.pone.0076206","article-title":"Pro-inflammatory action of MIF in acute myocardial infarction via activation of peripheral blood mononuclear cells","volume":"8","author":"White","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2014.09.010_bib22","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jcmg.2012.03.015","article-title":"Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion","volume":"5","author":"Chan","year":"2012","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.09.010_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/eurheartj\/ehm507","article-title":"Relationship between longitudinal morphology of ruptured plaques and TIMI flow grade in acute coronary syndrome: a three-dimensional intravascular ultrasound imaging study","volume":"29","author":"Tanaka","year":"2008","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.09.010_bib24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jcin.2010.02.010","article-title":"Morphological characteristics of culprit atheromatic plaque are associated with coronary flow after thrombolytic therapy: new implications of optical coherence tomography from a multicenter study","volume":"3","author":"Toutouzas","year":"2010","journal-title":"JACC Cardiovasc. Interv."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.09.010_bib25","doi-asserted-by":"crossref","first-page":"e19852","DOI":"10.1371\/journal.pone.0019852","article-title":"Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA\/KORA Augsburg case-cohort study","volume":"6","author":"Herder","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2014.09.010_bib26","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0002-9149(01)01850-1","article-title":"Elevation of plasma level of macrophage migration inhibitory factor in patients with acute myocardial infarction","volume":"88","author":"Yu","year":"2001","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.09.010_bib27","doi-asserted-by":"crossref","first-page":"e000226","DOI":"10.1161\/JAHA.113.000226","article-title":"Macrophage migration inhibitory factor for the early prediction of infarct size","volume":"2","author":"Chan","year":"2013","journal-title":"J.\u00a0Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.09.010_bib28","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.amjmed.2004.04.010","article-title":"Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk prospective population study","volume":"117","author":"Boekholdt","year":"2004","journal-title":"Am. J. Med."},{"key":"10.1016\/j.atherosclerosis.2014.09.010_bib29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.freeradbiomed.2013.05.018","article-title":"Assessment of macrophage migration inhibitory factor in humans: protocol for accurate and reproducible levels","volume":"63","author":"Sobierajski","year":"2013","journal-title":"Free Radic. Biol. Med."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014014087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014014087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:35:27Z","timestamp":1758155727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915014014087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0021915014014087"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.09.010","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of counterbalance between macrophage migration inhibitory factor and its inhibitor Gremlin-1 in patients with coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}